Skip to content

A study on the prevalence of diarrhea associated with proton pump inhibitors (PPIs)

A study on the prevalence of diarrhea associated with proton pump inhibitors (PPIs) - A study on the prevalence of diarrhea associated with proton pump inhibitors (PPIs)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000005300
Enrollment
300
Registered
2011-03-24
Start date
2011-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastroesophageal reflux disease and gastroduodenal ulcer etc.

Interventions

None listed

Sponsors

Shimane University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: outpatients who have been taking PPIs for over one month

Exclusion criteria

Exclusion criteria: patients who are diagnosed as irritable bowel syndrome, who take drug for constipation, and who take PPI on-demand basis

Design outcomes

Primary

MeasureTime frame
daily stool frequency, stool consistency using Bristol Stool Scale Form, and impaired QOL caused by diarrhea for one month

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026